Status:
NOT_YET_RECRUITING
Outcomes of Vaso-occlusive Crisis in Pediatric Sickle Cell Disease
Lead Sponsor:
Assiut University
Conditions:
Sickle Cell Disease
Vaso-occlusive Crisis
Eligibility:
All Genders
1-18 years
Brief Summary
This study aims to assess the incidence and clinical outcomes of vaso-occlusive crises in pediatric patients with sickle cell disease. Data will be collected and analyzed to identify risk factors and ...
Detailed Description
Sickle cell disease is a hereditary blood disorder characterized by the presence of sickle-shaped red blood cells, which leads to recurrent vaso-occlusive crises (VOC). These painful episodes are amon...
Eligibility Criteria
Inclusion
- Children aged 1-18 years. Confirmed diagnosis of sickle cell anemia by hemoglobin electrophoresis or high-performance liquid chromatography .
- History of at least one hospital visit or admission for vaso-occlusive crisis
Exclusion
- Patients with other hemoglobinopathies (e.g., thalassemia). Patients with incomplete medical records. Children with coexisting chronic diseases that may confound pain crises .
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2027
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT07200869
Start Date
October 1 2025
End Date
November 1 2027
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University
Asyut, Egypt